Navigation Links
Newly discovered molecule may offer hope for immune disorders and runaway inflammation
Date:3/31/2014

A new research discovery published in the April 2014 issue of the Journal of Leukocyte Biology may open the door to new therapies that help treat immune disorders or curb runaway inflammation. Specifically, scientists have discovered a molecule that can induce cell death (apoptosis) in a key type of immune cell (dendritic cells). With this understanding, it may be possible to develop new therapies that essentially shut down dendritic cell activity, and thereby reducing an immune reaction.

"We hope that our findings provide better understanding of immune regulation, which might give new insights into identifying new targets for immunotherapies,'" said Young Chul Sung, Ph.D., a researcher involved in the work from the Division of Integrative Bioscience and Biotechnology at the Pohang University of Science and Technology in Pohang, Korea.

To make this discovery, scientists used two groups of mice. One group was bred to lack the molecule believed to induce dendritic cell apoptosis and the second were normal (wild-type). Dendritic cells, obtained from the spleens of both groups of mice, were activated in vivo and in vitro, and apoptosis was determined by flow cytometry. Significantly lower apoptosis was found in the mice lacking the molecule necessary to induce apoptosis, when compared to their counterparts

"Dendritic cells are the essential inducers of immune responses and sense the need to activate many other immune cascades, but sometimes these cells get it wrong," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. "Understanding how one might selectively induce cell death in dendritic cells may reveal novel opportunities to eliminate these key orchestrators of immune responses in pathogenic settings such as autoimmunity or inflammatory diseases."


'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. Newly identified small-RNA pathway defends genome against the enemy within
2. Newly discovered catalyst could lead to the low-cost production of clean methanol
3. Newly discovered marsupial the victim of fatal attraction
4. Newly discovered signaling pathway could impact a variety of autoinflammatory diseases
5. Newly discovered human peptide may become a new treatment for diabetes
6. Attention Vical Incorporated Investors: Vical Misled Investors According to a Newly Filed Class Action
7. Newly identified proteins make promising targets for blocking graft-vs.-host disease
8. UF: Newly discovered tiger shark migration pattern might explain attacks near Hawaii
9. Newly discovered ocean plume could be major source of iron
10. Newly discovered switch plays dual role in memory formation
11. Newly discovered bacterial partnership changes ocean chemistry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/11/2014)... Inc., a Chicago -based digital forensics ... of Yaniv Schiff from Senior Computer Forensics ... role as Director, he will lead company efforts to ... provide leadership within the company,s digital forensics practice area.  ... Schiff joined Forensicon in 2006 and has ...
(Date:11/7/2014)... professor, biomedical engineering, in the Grove School of ... have identified a molecule that could lead to ... forms of breast cancer. , Triple negative breast ... to aggressive proliferation and metastasis and a lack ... discovered the overexpression of intercellular adhesion molecule-1 (ICAM-1) ...
(Date:11/7/2014)... CORAL SPRINGS, Florida , November 6, 2014 ... improved secure authentication for better mobile security revolutionizing online transactions. ... NXTD ), Alibaba Holdings Ltd. (NYSE: BABA ), ... MSFT ), eBay Inc. (NASDAQ: EBAY ... (NASDAQ: NXTD and NXTDW), a biometric authentication ...
Breaking Biology News(10 mins):Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6
... Scientists at Stanford University have developed a new laser ... unharmed. The new, non-invasive treatment is described in a ... the Proceedings of the National Academy of Sciences (PNAS). ... how to cure cancer without harming normal body tissue," ...
... from sensory neurons using a code more complicated than ... National Autonomous University of Mexico and Cold Spring Harbor ... when it touches the skin, scientists found that changes ... sensory signal is interpreted. , Howard Hughes Medical Institute ...
... looking deep under water for clues on how to ... Some of the stresses inherent with travel and life ... example - are not easily remedied with traditional plant ... Distinguished Professor of Botany, and Dr.Amy Grunden, assistant professor ...
Cached Biology News:Scientists develop nanotech-laser treatment that kills cancer cells without harming healthy tissue 2Scientists develop nanotech-laser treatment that kills cancer cells without harming healthy tissue 3Scientists develop nanotech-laser treatment that kills cancer cells without harming healthy tissue 4Cracking the perception code 2Cracking the perception code 3NC State researchers redesign life for Mars and beyond 2
(Date:11/15/2014)... BELLINGHAM, Washington, USA (PRWEB) November 14, 2014 ... enter the SPIE Startup Challenge 2015 , an ... team of business development experts and venture capitalists. The ... at the Moscone Center in San Francisco, running ... society for optics and photonics . , Cash prizes, ...
(Date:11/15/2014)... 14, 2014 Research ... addition of the  "Protein Characterization and Identification ... & by End Users - Global Forecast ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The global protein characterization ... million in 2014, and is expected to ...
(Date:11/12/2014)... November 12, 2014 The “Pen Needles ... 10mm, and 12mm), Therapy (Insulin, Growth Hormones, Glucagon-like peptide) ... & Global Forecast to 2019”analyzes and studies the major ... 101 market data tables and 51 figures spread through ... by Type (Standard and Safety), by Needle Length (4mm, ...
(Date:11/12/2014)... and ANNAPOLIS JUNCTION, MD (PRWEB) November 11, 2014 ... , Brian Meshkin, spoke at the 8th Annual ... in Pain Management . The Annual Pain and Migraine ... of pain research and emerging therapeutic methods. The event ... communities to learn about the cutting-edge advances in various ...
Breaking Biology Technology:New Photonics Entrepreneurs Need to Apply Now for SPIE Startup Challenge 2015 2New Photonics Entrepreneurs Need to Apply Now for SPIE Startup Challenge 2015 3Global Protein Characterization and Identification (Chromatography, Electrophoresis, Mass Spectroscopy) Market - Forecast to 2019 2Global Protein Characterization and Identification (Chromatography, Electrophoresis, Mass Spectroscopy) Market - Forecast to 2019 3Pen Needles Market worth $2,105 Million by 2019 - New Report by MarketsandMarkets 2Pen Needles Market worth $2,105 Million by 2019 - New Report by MarketsandMarkets 3Pen Needles Market worth $2,105 Million by 2019 - New Report by MarketsandMarkets 4President of Proove Biosciences, Brian Meshkin, Speaks at the 8th Annual Pain Therapeutics Summit 2President of Proove Biosciences, Brian Meshkin, Speaks at the 8th Annual Pain Therapeutics Summit 3
... Oncology Adjuvant Trial 9735 at 2007 San, ... Improved Overall Survival Versus ... Results presented at the,30th annual San Antonio ... early stage breast cancer who have had surgery, ...
... FDA-defined Valvulopathy Permitted to Enroll in 2nd and ... Screening Requirement Eliminated, SAN DIEGO, Dec. 13 ... announced the initiation of patient screening in,the second ... efficacy and,safety of its lead drug candidate, lorcaserin ...
... SAN DIEGO, Dec. 13 BioMed Realty Trust, Inc.,(NYSE: ... I. Gilchrist to its,board of directors, increasing the board ... in the real estate industry, with a breadth of,ability ... large-scale commercial real estate projects. We believe that,Rick,s contributions ...
Cached Biology Technology:Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 2Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 3Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 4Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 5Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 2Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 3Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 4Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 5Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 6BioMed Realty Trust Appoints Executive Officer of the Irvine Company to Its Board 2BioMed Realty Trust Appoints Executive Officer of the Irvine Company to Its Board 3
FITC~Bovine Serum Albumin...
Bovine Serum Albumin Heat Shock Diagnostic Grade Powder...
Ready for formulation or direct injection into animals Provided in convenient 100, 250, 1000 and 10,000 nmol sizes HPLC purified, salt free, sterile filtered, and endotoxin tested ...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Biology Products: